to estimate the residual beta-cell function , plasma glucose and c-peptide response to an intravenous injection of tolbutamide were observed in seven type i ( insulin dependent ) and nine type ii ( non-insulin dependent ) diabetic patients on insulin therapy .
C0021641
insulin
C0011860
non-insulin dependent